Sponsors & Supporters
Meet the Global Generics & Biosimilars 2018 Sponsors & Supporters
9 October 2018, Palacio Municipal de Congresos, Madrid, Spain.
IMS Health and Quintiles are now IQVIA.
Healthcare is an industry designed to help humans. As a global community, IQVIA continuously invest and commit to advancing human health. To deliver value and real outcomes. To rise to the challenge to find the next breakthrough by making the most of increasingly limited resources.
IQVIA are inspired by the potential and propelled by the possibilities. They share the vision to drive healthcare forward. To see how they can help accelerate progress and achievements. Others are developing these medical breakthroughs. They do their part by using breakthroughs in insights, technology and human intelligence to reimagine and deliver ways to help make them a reality.
It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about exploring a new path to better health outcomes via Human Data Science. It’s about harnessing the power of the IQVIA CORE™ to channel the insights, commercial and scientific depth, and executional expertise that drive maximum value for customers.
Motivated by the industry IQVIA help, they’re committed to providing solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward."
Millions of people around the world are suffering because they have little or no access to medicine and health care. They live in communities made vulnerable by conflict, displacement or natural disasters. They are expectant mothers in Africa and South Asia bleeding to death due to lack of access to medicine. They are refugee children in the Middle East in great pain because the hospital's supply of pain medication has run out. We want to eradicate this suffering.
IHP works hard to ensure that some of the unmet needs in our world can be met through safe and effective coordination of medical product donations. Founded in 2004, in response to the hugh need for medicine during the aftermath of the Asian Tsumami, they have continued to respond wherever the need is greatest, working with the healthcare industry and medical NGOs to send high quality medical aid.
Today IHP work with over 75 healthcare companies and 25 international medical NGOs in 106 countries to bring targeted medical relief.
mAbxience is a biotechnology company specialized in the research, development and manufacture of biosimilar monoclonal antibodies, part to the pharmaceutical Insud Pharma Group. Set up in 2009, it currently has two facilities for development and production, in Spain and Argentina. In December 2014, it launched its first biosimilar, rituximab, which is now approved and distributed in many markets globally. Its second product, bevacizumab, was launched in its first market in November 2016.
Formed in 2008, Panacea is a pharmaceutical and medical device consultancy company working on behalf of clients providing a wide range of supporting services.
Responsible for licences in every European Union country, and in other countries around the world, Panacea have a dedicated Quality Management function which ensures that all work – at every level – is checked, audited, and compared with best practice and complies with the highest and latest standards.
Panacea is pioneered by a highly qualified and experienced team of professionals. Senior members of the management team have gained postgraduate qualifications in Pharmacovigilance, and others are currently studying for the same qualification. Likewise, they have extensive experience of inspections from the MHRA and IMB, whilst the Head of Quality Function brings invaluable experience of working with the FDA.
Pharmawise is a specialist pharmaceutical consultancy. They give their clients strategic, commercial and scientific advice and support through our international network of industry experts.
With deep expertise in your sector, Pharmawise can help you tackle the most complex and specialised challenges; develop strategic and operational plans; and improve the efficiency of operations.
Pharmacloud was established in 2009 by Frances Cloud, who was previously an equity analyst and M&A adviser covering the European generic sector. Pharmacloud’s original focus was on writing research about the generic pharmaceutical industry, but since then it has expanded its activities to encompass commercial due diligence, market mapping, market entry strategies, strategic consultancy and M&A support. Europe remains the primary focus, but Pharmacloud has recently completed a number of projects in the US and is increasingly operating in MENA and other emerging markets. Pharmacloud has been involved in many if not most of the generic M&A transactions that have taken place in Europe over the last five years, mainly assisting PE, and is very active in identifying and diligencing big pharma tail end assets for a variety of trade and financial clients.
Piramal Pharma Solutions, a unit of Pirmal Enterprises is a Contract Development and Manufacturing Organisation (CDMO), and offers end-to-end development and manufacturing solutions across the drug life cycle. They serve thier clients through a globally integrated network of facilities in North America, Europe and Asia. It enables them to offer a comprehensive range of services from Drug Discovery Services to Development and Commercial manufacturing of APIs and Finished dosage forms.
With a pool of 450 scientists, including 155 Ph.Ds across the globe, Piramal offer specialised services like development and manufacture of Highly Potent APIs, Antibody Drug Conjugation and are well versed in technologies such as Bio-Catalysis. Their capability as an integrated service provider and experience with various cutting-edge technologies, enables them to effectively serve Innovator and Generic companies worldwide.
SanaClis was founded in 2000 by seasoned industry experts all of whom have had executive level positions in leading pharma companies and large global CROs. SanaClis is a full-service European CRO offering a comprehensive range of services for clinical trials.
SanaClis has experience of successfully delivering studies for various sized sponsors, starting from virtual biotechs through to top 10 pharma companies. Every project is a priority for the SanaClis team, irrespective size or scope.
At SanaClis they believe that every company and professional deserves to feel that they are getting the best possible service, responsiveness and dedication that we routinely provide to all of their existing clients.
In additional to being a full service CRO, SanaClis is one of the very few service providers who has in-house logistics capabilities. This includes QP services, customs brokerage, warehousing and distribution, and sourcing of clinical trial materials, comparators and rescue medication.
TAPI (Teva Active Pharmaceutical Ingredients)
With the industry’s broadest portfolio of more than 370 high quality API products, they serve nearly 1,000 customers in more than 100 countries. A stand-alone unit within Teva Pharmaceutical Industries, their history in the generic API industry dates back more than 80 years. Headquartered in Israel near Tel Aviv, TAPI employs 5,000 professionals at 18 sites worldwide. Their state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, India, China, Mexico, and the United States.
West Contract Manufacturing services harness a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. In addition to our more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging from eight locations throughout North America and Europe.